Biography
Jaejun Kim received his B.S. in Veterinary Medicine from Seoul National University. After that, he became a PhD student in College of Medicine at Seoul National University. His graduate research focused on the molecular mechanisms of direct reprogramming in the formation of induced stem cells. He is currently a member of the Willenbring lab in the Broad Center for Regenerative Medicine, where he is investigating AAV capsids for liver-targeted gene therapy.
Education
| Institution | Degree | Dept or School | End Date |
|---|---|---|---|
| Seoul National University | Ph.D. | 08/2018 | |
| Seoul National University | B.S. & D.V.M. | 02/2012 |
Awards & Honors
| Award | Conferred By | Date |
|---|---|---|
| California Institute for Regenerative Medicine (CIRM) Postdoctoral Fellowship | UCSF | 2022 |
Research Interests
Liver-targeted AAV
Publications
MOST RECENT PUBLICATIONS FROM A TOTAL OF 22
- Identification of a robust promoter in mouse and human hepatocytes by in vivo biopanning of a barcoded AAV library.| | PubMed
- AAV capsid prioritization in normal and steatotic human livers maintained by machine perfusion.| | PubMed
- Graphene Quantum Dots Alleviate Impaired Functions in Niemann-Pick Disease Type C in Vivo.| | PubMed
- Graphene quantum dots as anti-inflammatory therapy for colitis.| | PubMed
- cAMP/EPAC Signaling Enables ETV2 to Induce Endothelial Cells with High Angiogenesis Potential.| | PubMed
- Disease-specific primed human adult stem cells effectively ameliorate experimental atopic dermatitis in mice.| | PubMed
- Interferon-γ-mediated secretion of tryptophanyl-tRNA synthetases has a role in protection of human umbilical cord blood-derived mesenchymal stem cells against experimental colitis.| | PubMed
- Human umbilical cord blood plasma alleviates age-related olfactory dysfunction by attenuating peripheral TNF-α expression.| | PubMed
- Stem cell-secreted 14,15- epoxyeicosatrienoic acid rescues cholesterol homeostasis and autophagic flux in Niemann-Pick-type C disease.| | PubMed
- Single-Factor SOX2 Mediates Direct Neural Reprogramming of Human Mesenchymal Stem Cells via Transfection of In Vitro Transcribed mRNA.| | PubMed